Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Malignant Soft Tissue Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Not applicableUnknownNCT05107843
What this trial is testing

Integrated Clinical-radiological Analysis of Hypoxia Markers in Pediatric Osteosarcomas

Who this might be right for
Osteosarcoma in Children
University Hospital, Strasbourg, France 30
Testing effectiveness (Phase 2)UnknownNCT00790244
What this trial is testing

A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall

Who this might be right for
Soft Tissue SarcomaNon Metastatic Disease
Oslo University Hospital 188
Large-scale testing (Phase 3)UnknownNCT00002516
What this trial is testing

Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma

Who this might be right for
Sarcoma
University Hospital Muenster
Early research (Phase 1)Study completedNCT00004241
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+50 more
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Study completedNCT02049905
What this trial is testing

Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

Who this might be right for
Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
ImmunityBio, Inc. 433
Testing effectiveness (Phase 2)Active Not RecruitingNCT04733183
What this trial is testing

Efficacy and Safety of L19TNF in Previously Treated Patients with Advanced Stage or Metastatic Soft-tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Philogen S.p.A. 98
Early research (Phase 1)Looking for participantsNCT07746141
What this trial is testing

A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) Mutations

Who this might be right for
RAS MutationAdvanced Solid TumorMetastatic Solid Tumor
BeOne Medicines 100
Testing effectiveness (Phase 2)Study completedNCT01294202
What this trial is testing

Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Astex Pharmaceuticals, Inc. 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04803877
What this trial is testing

SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma

Who this might be right for
OsteosarcomaOsteosarcoma in ChildrenOsteosarcoma Recurrent+1 more
Sarcoma Alliance for Research through Collaboration 48
Not applicableLooking for participantsNCT06987370
What this trial is testing

SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue

Who this might be right for
Bone Metastases in Subjects With Advanced Cancer
Shandong Cancer Hospital and Institute 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03967223
What this trial is testing

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

Who this might be right for
Neoplasms
USWM CT, LLC 103
Not applicableLooking for participantsNCT04068155
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors

Who this might be right for
Skin CancerCutaneous TumorCutaneous Metastasis
Alpha Tau Medical LTD. 80
Large-scale testing (Phase 3)Ended earlyNCT03495921
What this trial is testing

A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide

Who this might be right for
Ewing SarcomaEwing Family of TumorsEwing's Tumor Metastatic+10 more
Gradalis, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT01719744
What this trial is testing

Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma

Who this might be right for
AdvancedMetastaticSoft Tissue Sarcoma
University Health Network, Toronto 25
Post-approval studies (Phase 4)Study completedNCT00003398
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
AnemiaGraft Versus Host DiseaseLeukemia+3 more
University of Maryland, Baltimore 45
Not applicableActive Not RecruitingNCT04671693
What this trial is testing

A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.

Who this might be right for
Late EffectsTesticular Germ Cell Tumor MixedNon-Metastatic Breast Carcinoma+6 more
Centre Leon Berard 500
Testing effectiveness (Phase 2)Ended earlyNCT04725331
What this trial is testing

A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors

Who this might be right for
Metastatic CancerSoft Tissue SarcomaMerkel Cell Carcinoma+3 more
Transgene 31
Testing effectiveness (Phase 2)Study completedNCT00427466
What this trial is testing

Pemetrexed in Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
University Hospital Tuebingen 54
Testing effectiveness (Phase 2)Study completedNCT01010672
What this trial is testing

Phase II Study of Ridaforolimus (MK-8669) With Metastatic Bone or Soft-tissue Sarcoma Patients (MK-8669-030 AM1)

Who this might be right for
Sarcoma
Merck Sharp & Dohme LLC 50
Next Page